Digital inhalers for asthma management
- PMID: 38411213
- DOI: 10.1097/MCP.0000000000001056
Digital inhalers for asthma management
Abstract
Purpose of review: Although digital inhaler systems for asthma management have been commercially available for over a decade, their current use in clinical practice is limited. This review outlines barriers and offers potential solutions to their implementation.
Recent findings: Digital inhaler systems demonstrate increased controller medication adherence, decreased quick-relief medication use, and improved asthma control.
Summary: Use of digital inhaler systems is supported by data from large clinical trials demonstrating improved asthma outcomes. Navigating telemedicine during the coronavirus disease 2019 pandemic has led to advances clearing the path for increased adoption of digital inhaler systems. Progress in areas including patient education and onboarding, clinical management, coding and billing, privacy and security have facilitated implementation in clinical practice.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Global Strategy for Asthma Management and Prevention. 2023. Global initiative for asthma. Available at: https://ginasthma.org/2023-gina-main-report/ [Accessed December 2023].
-
- GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396:1204–1222.
-
- Román-Rodríguez M, Metting E, Gacía-Pardo M, et al. Wrong inhalation technique is associated to poor asthma clinical outcomes. Is there room for improvement? Curr Opin Pulm Med 2019; 25:18–26.
-
- Rafi MA, Tahmin CI, Tashrik S, et al. Adherence to inhalers and associated factors among adult asthma patients: an outpatient-based study in a tertiary hospital of Rajshahi, Bangladesh. Asthma Res Pract 2022; 8:1.
-
- Hoyte FCL, Mosnaim GS, Rogers L, et al. Effectiveness of a digital inhaler system for patients with asthma: a 12-week, open-label, randomized study (CONNECT1). J Clin Immunol Pract 2022; 10:2579–2587.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
